Science, not politics, must guide lifesaving medical research

For more than three decades, my work has been rooted in West Baltimore, where the gap between scientific progress and community benefit is not theoretical; it is something families experience every day.

That is why a recent announcement about a new treatment for metastatic pancreatic cancer demanded my attention. New clinical data shows that daraxonrasib doubled survival rate for patients with previously treated metastatic pancreatic cancer, reducing the risk of death by 60 percent. Fore a disease that has long resisted treatment, this not not incremental progress-- it is a turning point...

Read more at AFRO News.